LSL Stock Overview
Develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
LSL Pharma Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.40 |
| 52 Week High | CA$0.55 |
| 52 Week Low | CA$0.34 |
| Beta | 0 |
| 1 Month Change | -11.11% |
| 3 Month Change | -14.89% |
| 1 Year Change | -11.11% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.67% |
Recent News & Updates
Shareholder Returns
| LSL | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | 5.3% | 2.7% | -4.1% |
| 1Y | -11.1% | 8.3% | 16.7% |
Return vs Industry: LSL underperformed the Canadian Personal Products industry which returned 5.4% over the past year.
Return vs Market: LSL underperformed the Canadian Market which returned 17.8% over the past year.
Price Volatility
| LSL volatility | |
|---|---|
| LSL Average Weekly Movement | 10.4% |
| Personal Products Industry Average Movement | 10.4% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.8% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: LSL has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: LSL's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 114 | Francois Roberge | www.groupelslpharma.com |
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical and natural health products in Canada. It offers dietary supplements and vitamins in the tablet and capsule form; and niche sterile ophthalmic products in the form of ointments and drops for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
LSL Pharma Group Inc. Fundamentals Summary
| LSL fundamental statistics | |
|---|---|
| Market cap | CA$42.75m |
| Earnings (TTM) | -CA$2.45m |
| Revenue (TTM) | CA$15.82m |
2.9x
P/S Ratio-18.8x
P/E RatioIs LSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSL income statement (TTM) | |
|---|---|
| Revenue | CA$15.82m |
| Cost of Revenue | CA$11.85m |
| Gross Profit | CA$3.98m |
| Other Expenses | CA$6.43m |
| Earnings | -CA$2.45m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | 25.13% |
| Net Profit Margin | -15.50% |
| Debt/Equity Ratio | 55.0% |
How did LSL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 05:30 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LSL Pharma Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|